A recent study reports that the level of N-methyl-D-aspartate (NMDA) glutamate receptor [70], dopamine receptors (DRD1-4), and HTR3 may potentially serve as peripheral biomarkers for schizophrenia [17]. The gene discussed is DRD1; the disease is schizophrenia.